University of Minnesota. Driven to Discover.
The trial of 40 adults with 2 dose levels found the vaccine safe and immunogenic.
The observational study found 46% protection but is smaller than an earlier one that showed no protection.
Varied efforts involve states, cities, food buyers, and hospital groups.
Tillerson voices support for US collaboration on global infectious disease issues, including those involving HIV and malaria.
Viral changes, birth year, repeat vaccinations, and waning protection may all play a role.
The Texas case is in a county where illnesses were reported last year.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyAcademic Health Center, University of Minnesota, Minneapolis, MN
© 2017 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.